JLR Q3 operating margin to fall, capex to rise in FY14

Wed Jan 23, 2013 7:40pm IST

A Jaguar Land Rover Freelander 2 vehicle is displayed for the media at the company's production plant in Pune, 190km south of Mumbai May 27, 2011. REUTERS/Danish Siddiqui/Files

A Jaguar Land Rover Freelander 2 vehicle is displayed for the media at the company's production plant in Pune, 190km south of Mumbai May 27, 2011.

Credit: Reuters/Danish Siddiqui/Files

Related Topics

Stocks

   

REUTERS - Jaguar Land Rover (JLR) is likely to report a lower EBITDA margin in the October-December quarter compared with the previous two quarters, the company said on Wednesday, due to exchange rate fluctuations and a higher mix of Evoque sales.

JLR's capital expenditure will rise to 2.75 billion pounds in the fiscal year that begins in April, up from 2 billion pounds in the current year, the company said in a statement, adding that free cash flow for 2013-14 could be negative as a result.

The British luxury brands, owned by India's Tata Motors(TAMO.NS), will report higher revenue in the quarter that ended in December than in the previous two quarters but similar EBITDA (earnings before interest, taxation, depreciation and amortisation), and will report a negative free cash flow in the period.

JLR reported EBITDA of 486 million pounds in the quarter to end-September, with an EBITDA margin of 14.8 percent.

(Reporting by Henry Foy in MUMBAI; Editing by Gopakumar Warrier)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Drug Pricing

REUTERS SHOWCASE

 G20 Meet

G20 Meet

As G20 chases growth goal, members differ on how to get there   Full Article 

Modi Speaks

Modi Speaks

PM Modi says al Qaeda will fail in India - CNN.  Full Article 

Alibaba Listing

Alibaba Listing

Alibaba surges on massive demand in trading debut  Full Article 

Importing Rice

Importing Rice

Top rice exporter India importing over 100,000 T on temporary supply squeeze.  Full Article 

GSK Fined

GSK Fined

China hands drugmaker GSK record $489 mln fine, sentences executives.  Full Article 

HMT in Demand

HMT in Demand

Fans rush to HMT as watchmaker marks time.  Full Article 

Apple Not Cool?

Apple Not Cool?

Some consumers say Apple is losing its "cool" factor  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage